𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy of peginterferon ALFA-2A (40KD) (PEGASYS) plud ribavirin for 24 weeks in genotype 1 patients with chronic hepatitis C followed by mono or combination therapy for 22 weeks: Preliminary analysis of an open, multicenter, randomized trial

✍ Scribed by J.P. Bronowicki; D. Ouzan; T. Asselah; H. Desmorat; J.P. Zarski; J. Foucher; M. Bourliere; C. Renous; A. Tran; P. Melin; C. Hezode; M. Chevallier; M. Bouvier; J.M. Pawlotsky; I. Lonjon-Domanec


Book ID
117372384
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
278 KB
Volume
38
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.